NCT03897842View on ClinicalTrials.gov

TARGET: A Study to Evaluate the Treatment of Patients With Acute Decompensated Heart Failure (ADHF) Using an Automated Fluid Management System

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

January 1, 2020

Conditions
Congestive Heart Failure
Interventions
DEVICE

Reprieve Cardiovascular System

The Reprieve Cardiovascular System (RCS) shall be utilized to maximize fluid removal over a maximum duration of 72 hours.

Trial Locations (1)

Unknown

RECRUITING

Military Hospital of Wroclaw, Wroclaw

Sponsors
All Listed Sponsors
lead

CardioRenal Systems, Inc.

INDUSTRY

NCT03897842 - TARGET: A Study to Evaluate the Treatment of Patients With Acute Decompensated Heart Failure (ADHF) Using an Automated Fluid Management System | Biotech Hunter | Biotech Hunter